✦ LIBER ✦

Safety and efficacy of a long-acting liposomal formulation of plasma-derived factor VIII in haemophilia A patients

✍ Scribed by Jack Spira; Olga Plyushch; Tatiana Andreeva; Vladimir Zorenko; Nadezhda Zozulya; Irena Velichkoi; Olga Ervinovna Zalepukhina; Rivka Yatuv; Moshe Baru

Book ID: 114714695
Publisher: John Wiley and Sons
Year: 2012
Tongue: English
Weight: 168 KB
Volume: 158
Category: Article
ISSN: 0007-1048
DOI: 10.1111/j.1365-2141.2012.09115.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Long-term efficacy and safety of a paste

Long-term efficacy and safety of a pasteurized, plasma-derived factor VIII concentrate (Beriate® P) in patients with haemophilia A

✍ Klamroth, Robert; Gottstein, Saskia; Orlovic, Marija; Heinrichs, Christl 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 223 KB

Interim data on long-term efficacy, safe

Interim data on long-term efficacy, safety and tolerability of a plasma-derived factor VIII concentrate in 109 patients with severe haemophilia A

✍ L. NEMES; H. POLLMANN; T. BECKER 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

Efficacy and safety evaluation of sucros

Efficacy and safety evaluation of sucrose-formulated recombinant factor VIII for Taiwanese patients with haemophilia A

✍ J.-H. YOUNG; H.-C. LIU; E.-J. HSUEH; M.-L. HUANG; C.-T. PENG; R.-L. CHEN; M. MAA 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 40 KB

Efficacy and safety of a novel long-acti

Efficacy and safety of a novel long-acting risperidone formulation

✍ J. Kane; M. Eerdekens; S. Keith; M. Lesem; K. Karcher; J.-P. Lindenmayer 📂 Article 📅 2002 🏛 Elsevier Science 🌐 French ⚖ 147 KB

Safety and efficacy of a sucrose-formula

Safety and efficacy of a sucrose-formulated recombinant factor VIII product for the treatment of previously treated patients with haemophilia A in China

✍ J. SHI; Y. ZHAO; J. WU; J. SUN; L. WANG; R. YANG 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 465 KB

Safety, pharmacokinetics and efficacy of

Safety, pharmacokinetics and efficacy of factor VIIa formulated with PEGylated liposomes in haemophilia A patients with inhibitors to factor VIII – an open label, exploratory, cross-over, phase I/II study

✍ J. SPIRA; O. PLYUSHCH; N. ZOZULYA; R. YATUV; I. DAYAN; A. BLEICHER; M. ROBINSON; 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 198 KB